As of 2025-02-09, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (0.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.80 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -119.4%.
The range of the Relative Valuation is (2.46) - 3.66 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 8.8x - 26.1x | 14.6x |
Forward P/E multiples | 16.3x - 40.1x | 24.4x |
Fair Price | (2.46) - 3.66 | (0.93) |
Upside | -151.3% - -23.8% | -119.4% |
Date | P/E |
2025-02-07 | -17.08 |
2025-02-06 | -16.69 |
2025-02-05 | -16.12 |
2025-02-04 | -15.94 |
2025-02-03 | -15.34 |
2025-01-31 | -15.69 |
2025-01-30 | -16.30 |
2025-01-29 | -16.12 |
2025-01-28 | -15.80 |
2025-01-27 | -15.83 |
2025-01-24 | -15.66 |
2025-01-23 | -15.73 |
2025-01-22 | -15.48 |
2025-01-21 | -16.05 |
2025-01-17 | -15.51 |
2025-01-16 | -15.80 |
2025-01-15 | -15.83 |
2025-01-14 | -15.58 |
2025-01-13 | -16.12 |
2025-01-10 | -16.37 |
2025-01-08 | -16.55 |
2025-01-07 | -17.26 |
2025-01-06 | -17.04 |
2025-01-03 | -17.26 |
2025-01-02 | -17.15 |
2024-12-31 | -17.04 |
2024-12-30 | -17.01 |
2024-12-27 | -17.11 |
2024-12-26 | -17.11 |
2024-12-24 | -17.19 |
2024-12-23 | -16.65 |
2024-12-20 | -17.01 |
2024-12-19 | -16.47 |
2024-12-18 | -16.19 |
2024-12-17 | -16.83 |
2024-12-16 | -16.47 |
2024-12-13 | -16.40 |
2024-12-12 | -16.44 |
2024-12-11 | -16.62 |
2024-12-10 | -16.37 |
2024-12-09 | -17.15 |
2024-12-06 | -17.22 |
2024-12-05 | -17.01 |
2024-12-04 | -17.22 |
2024-12-03 | -17.47 |
2024-12-02 | -17.93 |
2024-11-29 | -18.32 |
2024-11-27 | -18.47 |
2024-11-26 | -17.72 |
2024-11-25 | -17.97 |